FDC Ltd, a drug company from Mumbai, has had to recall more than 60,000 bottles of Timolol Maleate Ophthalmic Solution USP across the US. The trouble started when they found out the bottles were faulty the cap’s spike was getting jammed in the noz...
Empagliflozin, a widely used diabetes medication, after two weeks, went off patent.
Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and Drug Administration (USFDA) for Glatiramer Acetate Injection, 20 mg/mL and 40 mg/mL...
PharmaTrac, a market research firm, published data on Eli Lilly’s weight-loss drug Mounjaro has seen rapid growth in India just a month after its launch, with sales of the 2.5 mg injection jumping from Rs. 1.42 crore in March to Rs. 4.8 crore in Apri
According to Health Ministry officials, there are about 10,000 medium and small manufacturing businesses and only 100 of them submitted applications.
The National Pharmaceutical Pricing Authority (NPPA) has set 84 drug formulations' retail prices, including 36 formulations of empagliflozin, a diabetes drug that was originally developed by German firm Boehringer Ingelheim...
A significant attempt to stop illegal sale of narcotic and psychotropic drugs has been made by the Gujarat Food and Drugs Control Administration (FDCA) in a major crackdown effort on the illicit sale of drugs in the state...
Sun Pharmaceutical Industries Limited (Sun Pharma), India's largest pharmaceutical company, has initiated a brand campaign that celebrates its contribution to the lives of people. Called 'touching 1,000...
The Pharma Quality Excellence Awards 2025 ceremony marked a significant milestone in recognizing outstanding contributions to pharmaceutical quality standards. Held in Hotel Westin Mumbai Garden City, it brought together industry leaders, quality pro
Pharma Science, a leader in India's Ayurvedic healthcare industry, is revolutionizing natural wellness with clinically proven, patented products and an open business model...